Summary: Guidance on the use of paclitaxel in the treatment of ovarian cancer information
History
Documents created during the development process.
Other information
Background information
-
Ovarian cancer - paclitaxel (review): static list review decision - August 2015 information
-
Ovarian cancer - paclitaxel (review): appendix A - static list review paper - August 2015
-
-
-
Review decision - October 2009: appendix A - decision paper considered by the Institute's Guidance Executive
-
-
-
Review proposal - August 2009: appendix A - provisional matrix
-
Review proposal - August 2009: appendix A - provisional matrix (PDF 37 KB)
-
Review proposal - August 2009: appendix B - proposal paper
-
Review proposal - August 2009: appendix B - proposal paper (PDF 167 KB)
-
Decision of the Appeal Panel: Appraisal of Paclitaxel for Ovarian Cancer
-
Decision of the Appeal Panel: Appraisal of Paclitaxel for Ovarian Cancer (PDF 80 KB)
-
Assessment Report: An update of a rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of ovarian cancer
-
-
Review update on the use of paclitaxel (1st line only) in the treatment of ovarian cancer
-